Nexera Technologies updates warrant exercise price
Nexera Technologies Ltd has adjusted the exercise price of certain warrants.
Rhea-AI Filing Summary
Nexera Technologies Ltd has adjusted the exercise price of certain warrants. Effective as of June 1, 2026, the exercise price per whole ordinary share issuable upon exercise of the outstanding Series A Warrants and the Note Warrant tied to a convertible promissory note was set at $1.014992 per share, subject to any further adjustments under their terms. The company states that no other changes, adjustments or modifications were made to these warrants. This update is also incorporated by reference into several of Nexera’s existing Form F-3 and Form S-8 registration statements.
Positive
- None.
Negative
- None.
Key Figures
Warrant exercise price: $1.014992 per share
1 metrics
Warrant exercise price
$1.014992 per share
Exercise price for outstanding Series A Warrants and Note Warrant effective June 1, 2026
Key Terms
Series A Warrants, convertible promissory note, exercise price, Form F-3, +2 more
6 terms
Series A Warrants financial
"pursuant to Section 2(a) of the Series A Warrants dated January 29, 2024"
Series A warrants are financial tools that give the holder the right to buy shares of a company at a specific price within a certain period. They are often issued alongside investments to provide additional potential profit if the company's value increases. For investors, they can offer a chance to benefit from future growth without committing immediate capital to buying shares.
convertible promissory note financial
"amended and restated warrant to purchase Ordinary Shares, issued in connection with a convertible promissory note"
A convertible promissory note is a loan a company takes now that can later be turned into shares instead of being repaid in cash. Think of it as lending money with the option to accept ownership in the business down the road; that matters to investors because it affects who gets paid first, how much ownership existing shareholders keep, and the company’s future valuation and cash needs. Terms such as conversion price, interest and maturity determine the financial impact.
exercise price financial
"the exercise price per each whole Ordinary Share issuable upon exercise of the outstanding Series A Warrants and the Note Warrant was adjusted"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Form F-3 regulatory
"Registration Statements on Form F-3 (File No. 333-277188, File No. 333-262835"
Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.
Form S-8 regulatory
"Registration Statements on Form S-8 (File No. 333-269119, File No. 333-280459"
A Form S-8 is a U.S. Securities and Exchange Commission registration that lets a public company set aside shares for employee benefit plans and stock-based compensation. Think of it as opening a dedicated account that authorizes the company to issue or reserve stock for workers and directors; it matters to investors because it enables share dilution when those awards are granted or exercised and signals how management is compensated and incentivized.
Form 6-K regulatory
"This Form 6-K is incorporated by reference into the Company’s Registration Statements"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What change did Nexera Technologies Ltd (JFBR) report in its June 2026 Form 6-K?
Nexera Technologies Ltd reported an adjustment to the exercise price of its outstanding Series A Warrants and a Note Warrant. The updated price is $1.014992 per ordinary share, effective June 1, 2026, with no other changes to the warrant terms.
Which Nexera Technologies (JFBR) securities are affected by the new $1.014992 exercise price?
The updated $1.014992 exercise price applies to Nexera’s outstanding Series A Warrants dated January 29, 2024, and the amended and restated Note Warrant issued with a convertible promissory note dated May 10, 2026, both for ordinary shares.
When does Nexera Technologies’ adjusted warrant exercise price of $1.014992 become effective?
The adjusted exercise price of $1.014992 per ordinary share is effective as of June 1, 2026. From that date, holders of the outstanding Series A Warrants and the Note Warrant use this price, subject to any future adjustments allowed under their terms.
Did Nexera Technologies (JFBR) change any other terms of its warrants in this 6-K?
No. Nexera specifically states that no other changes, adjustments or modifications were made to the Series A Warrants or the Note Warrant. Only the exercise price per ordinary share was adjusted, leaving all other provisions intact.
How is Nexera Technologies’ June 2026 Form 6-K used in its registration statements?
The June 2026 Form 6-K is incorporated by reference into multiple Nexera registration statements on Forms F-3 and S-8. This means the warrant exercise price adjustment is legally included in those registration documents from the submission date onward.
AI-generated analysis. How Rhea-AI works. Not financial advice.
